Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Albert M. Anderson, Melinda K. Higgins, Raymond L. Ownby & Drenna Waldrop-Valverde. (2015) Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence. AIDS Care 27:3, pages 333-337.
Read now
Read now
Tatiana M. Davidson, Cristina M. Lopez, Raelle Saulson, April L. Borkman, Kathryn Soltis, Kenneth J. Ruggiero, Michael de Arellano, Gina M. Wingood, Ralph J. DiClemente & Carla Kmett Danielson. (2014) Development and preliminary evaluation of a behavioural HIV-prevention programme for teenage girls of Latino descent in the USA. Culture, Health & Sexuality 16:5, pages 533-546.
Read now
Read now
Ifeoma Ezeabogu, MichaelM. Copenhaver & Jessica Potrepka. (2012) The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care 24:3, pages 386-393.
Read now
Read now
Articles from other publishers (15)
Colleen B Mistler, Roman Shrestha, John Gunstad, Linda Collins, Lynn Madden, Tania Huedo-Medina, Brian Sibilio, Nicholas M Copenhaver & Michael Copenhaver. (2023) Application of the multiphase optimisation strategy (MOST) to optimise HIV prevention targeting people on medication for opioid use disorder (MOUD) who have cognitive dysfunction: protocol for a MOST study. BMJ Open 13:6, pages e071688.
Crossref
Crossref
Jennifer L. Glick, Aimee Huang, Rienna Russo, Belinda Jivapong, Vijayasundaram Ramasamy, Lori Rosman, Danielle Pelaez, Katherine H.A. Footer & Susan G. Sherman. (2020) ART uptake and adherence among women who use drugs globally: A scoping review. Drug and Alcohol Dependence 215, pages 108218.
Crossref
Crossref
Roman Shrestha, Frederick L. Altice, Brian Sibilio, Jude Ssenyonjo & Michael M. Copenhaver. (2019) Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study. Contemporary Clinical Trials 82, pages 77-84.
Crossref
Crossref
Roman Shrestha, Frederick L. Altice, Brian Sibilio & Michael M. Copenhaver. (2018) HIV Sero-Status Non-disclosure Among HIV-Infected Opioid-Dependent Individuals: The Roles of HIV-Related Stigma, Risk Behavior, and Social Support. Journal of Community Health 44:1, pages 112-120.
Crossref
Crossref
A Ocampo, P Domingo, P Fernández, J Diz, J R Barberá, M A Sepúlveda, X Salgado, M Rodriguez, J Santos, M Yzusqui, M I Mayorga, J F Lorenzo, A Bahamonde, P Bachiller, E Martínez, N Rozas, C Torres, A Muñoz, A Casado & D Podzamczer. (2018) Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study. Journal of Antimicrobial Chemotherapy 73:8, pages 2171-2176.
Crossref
Crossref
Gail Gilchrist, Davina Swan, April Shaw, Ada Keding, Sarah Towers, Noel Craine, Alison Munro, Elizabeth Hughes, Steve Parrott, Noreen Mdege, John Strang, Avril Taylor & Judith Watson. (2017) Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trial. Health Technology Assessment 21:72, pages 1-312.
Crossref
Crossref
Roman Shrestha, Pramila Karki, Tania B. Huedo-Medina & Michael Copenhaver. (2017) Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment. Journal of the Association of Nurses in AIDS Care 28:1, pages 85-94.
Crossref
Crossref
Roman Shrestha, Pramila Karki, Santosh Pandey & Michael Copenhaver. (2016) Adapting an Evidence-Based HIV Prevention Intervention Targeting High-Risk Migrant Workers: The Process and Outcome of Formative Research. Frontiers in Public Health 4.
Crossref
Crossref
Roman Shrestha, Archana Krishnan, Frederick L. Altice & Michael Copenhaver. (2015) A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description. Contemporary Clinical Trials 44, pages 95-102.
Crossref
Crossref
Dahye L. Song, Frederick L. Altice, Michael M. Copenhaver & Elisa F. Long. (2015) Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States. PLOS ONE 10:2, pages e0116694.
Crossref
Crossref
Jennifer M. Stewart. (2014) Implementation of Evidence‐Based HIV Interventions for Young Adult African American Women in Church Settings. Journal of Obstetric, Gynecologic & Neonatal Nursing 43:5, pages 655-663.
Crossref
Crossref
Matthew B. Feldman, Andrew Silapaswan, Nathan Schaefer & Daniel Schermele. (2014) Is There Life After DEBI? Examining Health Behavior Maintenance in the Diffusion of Effective Behavioral Interventions Initiative. American Journal of Community Psychology 53:3-4, pages 286-313.
Crossref
Crossref
William A. Fisher, Jeffrey D. Fisher & Paul A. Shuper. 2014.
105
193
.
Mariana ArcayaXavier de Souza Briggs. (2011) Despite Obstacles, Considerable Potential Exists For More Robust Federal Policy On Community Development And Health. Health Affairs 30:11, pages 2064-2071.
Crossref
Crossref
S. A. Springer, A. C. Spaulding, J. P. Meyer & F. L. Altice. (2011) Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components. Clinical Infectious Diseases 53:5, pages 469-479.
Crossref
Crossref